Levetiracetam Kalceks

Levetiracetam Kalceks is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.

Levetiracetam Kalceks is indicated as adjunctive therapy
• in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
• in the treatment of primary generalised tonic clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Levetiracetam Kalceks concentrate is an alternative for patients when oral administration is temporarily not feasible.

Prescription-only medicine. Information for healthcare professionals only.
For full information about this medicine, refer to the Summary of Product Characteristics.
Advertisement developed or revised 05/2026. Advertiser: AS Kalceks.